Magnesium in Aneurysmal Subarachnoid Haemorrhage

Phase 3

Completed

• Conditions: Aneurysmal subarachnoid haemorrhage; Circulatory System; Subarachnoid haemorrhage

• Registration Number: ISRCTN68742385
• Lead Sponsor: niversity Medical Centre Utrecht (UMCU) (The Netherlands)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2005-08-04
• Last Update Posted: 17 October 2016

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 1200

Inclusion Criteria

Aneurysmal subarachnoid haemorrhage

Exclusion Criteria

1. Renal failure (creatinine greater than 150)
2. Age less than 18 years
3. Weight less than 50 kg
4. No informed consent
5. Death is imminent

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Poor outcome (dependence or death) 3 months after the subarachnoid haemorrhage (Rankin 0 - 3 versus Rankin 4 - 5, or death) as assessed with the modified Rankin scale during a telephone interview. Dependence will be defined as a Rankin score greater than 3.

Secondary Outcome Measures

Name	Time	Method
1. No symptoms 3 months after the subarachnoid haemorrhage (Rankin 0 versus Rankin 1 - 5 or death)<br>2. Global change in Rankin score